Gyros awarded Frost & Sullivan Technology of the Year Award in the Field of Laboratory Automation
Frost & Sullivan’s Excellence in Technology Award is given to the company that has pioneered the development and introduction of an innovative technology into the market; a technology that has either impacted or has the potential to impact several market sectors. The award recognizes the company’s successful technology development that is expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. It also recognizes the overall technical excellence of the company and its commitment towards technology innovation.
Gyrolab Workstation enables researchers to generate more information from fewer samples and improves lab performance by streamlining the many steps of conventional applications into single, nanoliter scale procedures. The fully automated solution significantly shortens analysis time and reduces sample and reagent consumption. The technology is currently used for protein analysis applications within research, drug discovery and development, and in vitro diagnostics for medical applications in collaboration with partners.
Commenting on the award, Jan Würtz, CEO & President of Gyros AB said; “This is a fantastic achievement and we are obviously delighted to receive the award. It is especially satisfying to know that the significant and unique benefits offered by Gyros technology are becoming more widely recognized in what is a very competitive market place.”
“It is also a great reward for everybody within the company who have worked so hard in developing the technology and successfully bringing it to market”, added Mr. Würtz.
About Gyros AB
Gyros miniaturizes and integrates laboratory applications, enabling scientists to generate more information from less sample and to improve lab performance. Using our proprietary technology platform, we increase productivity by streamlining the many steps of conventional applications into single, nanoliter scale procedures. Optimal environments are created for each application.
A Gyrolab microlaboratory, in the form of a compact disk, can process hundreds of samples in parallel, under the control of Gyrolab Workstation.
Our company will realize the full potential of the Gyros technology platform in the fields of drug discovery and diagnostics. Initial product offerings are focused towards the growing area of proteomics. Gyros has 65 employees working at its headquarters in Uppsala Science Park, Sweden and in sales offices in the USA and Europe.
For further information, visit www.gyros.com
